944 related articles for article (PubMed ID: 18416843)
21. Apolipoprotein E genotype in sporadic early- and late-onset Alzheimer's disease.
Masullo C; Daniele A; Seripa D; Filippini V; Gravina C; Carbone G; Gainotti G; Fazio VM
Dement Geriatr Cogn Disord; 1998; 9(3):121-5. PubMed ID: 9621997
[TBL] [Abstract][Full Text] [Related]
22. Apolipoprotein E polymorphism and age of onset for Alzheimer's disease in a bi-ethnic sample.
Harwood DG; Barker WW; Ownby RL; St George-Hyslop P; Mullan M; Duara R
Int Psychogeriatr; 2004 Sep; 16(3):317-26. PubMed ID: 15559755
[TBL] [Abstract][Full Text] [Related]
23. [Correlation between Apolipoprotein E polymorphism and age at onset of Alzheimer's disease in a Chinese Han population].
Wang JT; Li L; Yuan J; Zhang ZX
Zhonghua Yi Xue Za Zhi; 2013 Jan; 93(3):182-6. PubMed ID: 23570590
[TBL] [Abstract][Full Text] [Related]
24. [ACT/AA polymorphism could duplicate the APOE*epsilon4-associated Alzheimer's disease risk].
Hernández-Charro B; Moreno S; Valiente A; Manubens JM; Villar MD; Ramos-Arroyo MA
Med Clin (Barc); 2004 Sep; 123(7):251-4. PubMed ID: 15482730
[TBL] [Abstract][Full Text] [Related]
25. Apolipoprotein E polymorphism in elderly Chilean people with Alzheimer's disease.
Quiroga P; Calvo C; Albala C; Urquidi J; Santos JL; Pérez H; Klaassen G
Neuroepidemiology; 1999; 18(1):48-52. PubMed ID: 9831815
[TBL] [Abstract][Full Text] [Related]
26. APOE genotypes as a risk factor for age-dependent accumulation of cerebrovascular disease in older adults.
Lamar M; Yu L; Rubin LH; James BD; Barnes LL; Farfel JM; Gaiteri C; Buchman AS; Bennett DA; Schneider JA
Alzheimers Dement; 2019 Feb; 15(2):258-266. PubMed ID: 30321502
[TBL] [Abstract][Full Text] [Related]
27. Association of Rare APOE Missense Variants V236E and R251G With Risk of Alzheimer Disease.
Le Guen Y; Belloy ME; Grenier-Boley B; de Rojas I; Castillo-Morales A; Jansen I; Nicolas A; Bellenguez C; Dalmasso C; Küçükali F; Eger SJ; Rasmussen KL; Thomassen JQ; Deleuze JF; He Z; Napolioni V; Amouyel P; Jessen F; Kehoe PG; van Duijn C; Tsolaki M; Sánchez-Juan P; Sleegers K; Ingelsson M; Rossi G; Hiltunen M; Sims R; van der Flier WM; Ramirez A; Andreassen OA; Frikke-Schmidt R; Williams J; Ruiz A; Lambert JC; Greicius MD; ; Arosio B; Benussi L; Boland A; Borroni B; Caffarra P; Daian D; Daniele A; Debette S; Dufouil C; Düzel E; Galimberti D; Giedraitis V; Grimmer T; Graff C; Grünblatt E; Hanon O; Hausner L; Heilmann-Heimbach S; Holstege H; Hort J; Jürgen D; Kuulasmaa T; van der Lugt A; Masullo C; Mecocci P; Mehrabian S; de Mendonça A; Moebus S; Nacmias B; Nicolas G; Olaso R; Papenberg G; Parnetti L; Pasquier F; Peters O; Pijnenburg YAL; Popp J; Rainero I; Ramakers I; Riedel-Heller S; Scarmeas N; Scheltens P; Scherbaum N; Schneider A; Seripa D; Soininen H; Solfrizzi V; Spalletta G; Squassina A; van Swieten J; Tegos TJ; Tremolizzo L; Verhey F; Vyhnalek M; Wiltfang J; Boada M; García-González P; Puerta R; Real LM; Álvarez V; Bullido MJ; Clarimon J; García-Alberca JM; Mir P; Moreno F; Pastor P; Piñol-Ripoll G; Molina-Porcel L; Pérez-Tur J; Rodríguez-Rodríguez E; Royo JL; Sánchez-Valle R; Dichgans M; Rujescu D
JAMA Neurol; 2022 Jul; 79(7):652-663. PubMed ID: 35639372
[TBL] [Abstract][Full Text] [Related]
28. Association of
Qian J; Betensky RA; Hyman BT; Serrano-Pozo A
Neurology; 2021 May; 96(19):e2414-e2428. PubMed ID: 33771840
[TBL] [Abstract][Full Text] [Related]
29. Impact of APOE genotype on neuropathologic and neurochemical markers of Alzheimer disease.
Tiraboschi P; Hansen LA; Masliah E; Alford M; Thal LJ; Corey-Bloom J
Neurology; 2004 Jun; 62(11):1977-83. PubMed ID: 15184600
[TBL] [Abstract][Full Text] [Related]
30. Apolipoprotein E epsilon4 and age at onset of sporadic and familial Alzheimer disease in Caribbean Hispanics.
Olarte L; Schupf N; Lee JH; Tang MX; Santana V; Williamson J; Maramreddy P; Tycko B; Mayeux R
Arch Neurol; 2006 Nov; 63(11):1586-90. PubMed ID: 17101827
[TBL] [Abstract][Full Text] [Related]
31. Deficiency in mitochondrial aldehyde dehydrogenase increases the risk for late-onset Alzheimer's disease in the Japanese population.
Kamino K; Nagasaka K; Imagawa M; Yamamoto H; Yoneda H; Ueki A; Kitamura S; Namekata K; Miki T; Ohta S
Biochem Biophys Res Commun; 2000 Jun; 273(1):192-6. PubMed ID: 10873585
[TBL] [Abstract][Full Text] [Related]
32. Apolipoprotein E epsilon4, Alzheimer's disease, and cognitive performance in elderly Mexican Mestizos.
Villalpando-Berumen JM; Mejia-Arango S; Aguilar-Salinas CA; Ordonez-Sanchez ML; Gutierrez-Robledo LM
J Am Geriatr Soc; 2008 Apr; 56(4):677-82. PubMed ID: 18205760
[TBL] [Abstract][Full Text] [Related]
33. Apolipoprotein E and Alzheimer disease: genotype-specific risks by age and sex.
Bickeböller H; Campion D; Brice A; Amouyel P; Hannequin D; Didierjean O; Penet C; Martin C; Pérez-Tur J; Michon A; Dubois B; Ledoze F; Thomas-Anterion C; Pasquier F; Puel M; Demonet JF; Moreaud O; Babron MC; Meulien D; Guez D; Chartier-Harlin MC; Frebourg T; Agid Y; Martinez M; Clerget-Darpoux F
Am J Hum Genet; 1997 Feb; 60(2):439-46. PubMed ID: 9012418
[TBL] [Abstract][Full Text] [Related]
34. The effect of APOE epsilon4 allele on cerebral glucose metabolism in AD is a function of age at onset.
Hirono N; Hashimoto M; Yasuda M; Ishii K; Sakamoto S; Kazui H; Mori E
Neurology; 2002 Mar; 58(5):743-50. PubMed ID: 11889238
[TBL] [Abstract][Full Text] [Related]
35. A luteinizing hormone receptor intronic variant is significantly associated with decreased risk of Alzheimer's disease in males carrying an apolipoprotein E epsilon4 allele.
Haasl RJ; Ahmadi MR; Meethal SV; Gleason CE; Johnson SC; Asthana S; Bowen RL; Atwood CS
BMC Med Genet; 2008 Apr; 9():37. PubMed ID: 18439297
[TBL] [Abstract][Full Text] [Related]
36. Accelerated decline in apolipoprotein E-epsilon4 homozygotes with Alzheimer's disease.
Craft S; Teri L; Edland SD; Kukull WA; Schellenberg G; McCormick WC; Bowen JD; Larson EB
Neurology; 1998 Jul; 51(1):149-53. PubMed ID: 9674794
[TBL] [Abstract][Full Text] [Related]
37. APOE ε4 is associated with earlier symptom onset in LOAD but later symptom onset in EOAD.
Polsinelli AJ; Lane KA; Manchella MK; Logan PE; Gao S; Apostolova LG
Alzheimers Dement; 2023 May; 19(5):2212-2217. PubMed ID: 36722399
[TBL] [Abstract][Full Text] [Related]
38. Apolipoprotein E genotypes associated with Alzheimer disease and concomitant stroke.
Fekih-Mrissa N; Klai S; Mrad M; Mansour M; Zaouali J; Gritli N; Mrissa R
J Stroke Cerebrovasc Dis; 2014 Apr; 23(4):681-5. PubMed ID: 23871727
[TBL] [Abstract][Full Text] [Related]
39. Apolipoprotein E gene in physiological and pathological aging.
Ferri E; Gussago C; Casati M; Mari D; Rossi PD; Ciccone S; Cesari M; Arosio B
Mech Ageing Dev; 2019 Mar; 178():41-45. PubMed ID: 30658061
[TBL] [Abstract][Full Text] [Related]
40. Risk-reducing effect of education in Alzheimer's disease.
Sando SB; Melquist S; Cannon A; Hutton M; Sletvold O; Saltvedt I; White LR; Lydersen S; Aasly J
Int J Geriatr Psychiatry; 2008 Nov; 23(11):1156-62. PubMed ID: 18484674
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
